Sex differences in glycemic outcomes: a systematic review and meta-analysis of diabetes treatments
Liu C, Mujahid O, Beneyto A, et al.
BMJ Open Diabetes Res Care. Pub. online 22 Apr 2026.
Leggi
Cardiovascular outcome trials (CVOTs) in cardiorenal metabolic medicine: a decade of transformative progress (2016-2026)
Wen S, Wang C, Xu Z, et al.
Cardiovasc Diabetol. Pub. online 24 Apr 2026.
Leggi
Low uptake and disparities in therapeutic inertia of cardiorenal protective diabetes medications for patients with type 2 diabetes and above-target hemoglobin A1c
German J, Huang WA, Brucker A, et al.
BMJ Open Diabetes Res Care. Pub. online 22 Apr 2026.
Leggi
Implementation of sodium-glucose co-transporter 2 inhibitors use in patients with heart failure across the ejection fraction: data from the Swedish heart failure registry
Ferrannini G, Musella F, Benson L, et al.
Eur Heart J Qual Care Clin Outcomes. Pub. online 19 Apr 2026.
Leggi
Feasibility of using OGTT 1-h PG as a diagnostic criterion for diabetes and pre-diabetes
Chen L, Bian B, Ran H, et al.
BMJ Open Diabetes Res Care. Pub. online 22 Apr 2026.
Leggi
Evaluation of large language models for carbohydrate counting in type 1 diabetes mellitus: a comparative study with patient estimations
Soyer AK, Akarsu GÇ, Yelli BD, et al.
Diabetes Res Clin Pract. Pub. online 25 Apr 2026.
Leggi
Novel OGTT metrics do not provide incremental predictive value beyond conventional glycemic criteria for remission of prediabetes in individuals with impaired fasting glucose: results from the PREVIEW trial
Zhu R, Guo J, Stratton G, et al.
Cardiovasc Diabetol. Pub. online 22 Apr 2026.
Leggi
Efficacy and safety of anagliptin added to metformin and empagliflozin 25 mg in patients with type 2 diabetes: a 24-week randomized, double-blind, placebo-controlled phase 3 trial with 28-week open-label extension
Moon JS, Han KA, Yu JM, et al.
Diabetes Res Clin Pract. Pub. online 24 Apr 2026.
Leggi
Documento congiunto AIMO–AMD–SID–SISO: screening della retinopatia
Cari Soci, vi informiamo che è disponibile sul sito AMD il documento intersocietario AIMO–AMD–SID–SISO: “L’attuazione dello screening della retinopatia diabetica nella realtà assistenziale italiana”. Documento intersocietario: https://aemmedi.it/wp-content/uploads/2026/04/Documento-intersocietario-AIMO-AMD-SID-SISO_Screening-RD.pdf Executive Summary: https://aemmedi.it/wp-content/uploads/2026/04/Executive-Summary-Documento-intersocietario-AIMO-AMD-SID-SISO_Screening-RD.pdf Lo screening della retinopatia diabetica è di particolare rilevanza per l’elevata prevalenza (30–40%), la lunga fase asintomatica, la semplicità e…
Leggi
IN RICORDO DEL PROFESSOR DOMENICO FEDELE
Esprimiamo il nostro cordoglio per la scomparsa del Professor Domenico Fedele, considerato uno dei padri fondatori della diabetologia italiana. Nel suo lungo e prestigioso percorso accademico ha contribuito in modo importante all’evoluzione della diabetologia superando l'approccio basato sulla “glicemologia” e contribuendo a favorire un orientamento basato sulla visione globale della…
Leggi